HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroendocrine correlates of depression in abstinent heroin-dependent subjects.

Abstract
The functions of the central alpha-adrenergic, serotoninergic and dopaminergic systems were investigated in 28 heroin-dependent subjects 6-8 weeks after detoxification, and in 22 healthy control subjects (group C). Fourteen heroin-dependent subjects with depressive comorbidity (group A), and 14 heroin-dependent subjects without other Axis I and II pathologies (group B) were included among abstinent substance abusers. Norepinephrine (NE) function was evaluated by growth hormone (GH) responses to acute stimulation with clonidine (clon); serotonin (5-HT) function by prolactin (PRL) and cortisol (CORT) responses to acute stimulation with D-fenfluramine (D-fen) and dopamine (DA) function by GH and PRL responses to acute administration of bromocriptine (brom). Central NE activity, as measured by the GH-clon test, seems to be well preserved both in A and B subjects. PRL and CORT responses to D-fen were significantly blunted both in A subjects and in B subjects, in comparison with control subjects (C); the PRL response in A subjects was significantly lower than in B subjects. The DA system of B subjects was found unimpaired; in contrast, a significantly higher GH response to brom in A subjects (depressed) could express D2 post-synaptic receptor hypersensitivity and, therefore, decreased pre-synaptic DA release. In sum, the study of central monoamine function revealed an alteration only of the 5-HT system in detoxified heroin-dependent subjects without psychiatric comorbidity, which might be a trait character of these subjects, possibly involved in the pathogenesis of the disorder. A more significant impairment of 5-HT function and the hypersensitivity of post-synaptic DA receptors in A subjects suggests that specific biological correlates of psychiatric comorbidity may characterize substance abuser subtypes.
AuthorsG Gerra, A Zaimovic, U Zambelli, R Delsignore, M C Baroni, G Laviola, T Macchia, F Brambilla
JournalPsychiatry research (Psychiatry Res) Vol. 96 Issue 3 Pg. 221-34 (Nov 20 2000) ISSN: 0165-1781 [Print] Ireland
PMID11084218 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Adrenergic alpha-Agonists
  • Biomarkers
  • Dopamine Agonists
  • Receptors, Adrenergic
  • Receptors, Dopamine
  • Receptors, Serotonin
  • Serotonin Agents
  • Fenfluramine
  • Serotonin
  • Bromocriptine
  • Clonidine
  • Dopamine
  • Norepinephrine
Topics
  • Adrenergic alpha-Agonists (pharmacology)
  • Adult
  • Analysis of Variance
  • Biomarkers
  • Brain (metabolism)
  • Bromocriptine (pharmacology)
  • Case-Control Studies
  • Clonidine (pharmacology)
  • Depression (metabolism)
  • Depressive Disorder, Major (metabolism, psychology)
  • Diagnosis, Dual (Psychiatry)
  • Dopamine (metabolism)
  • Dopamine Agonists (pharmacology)
  • Female
  • Fenfluramine (pharmacology)
  • Heroin Dependence (metabolism, psychology, therapy)
  • Humans
  • Male
  • Norepinephrine (metabolism)
  • Psychiatric Status Rating Scales
  • Receptors, Adrenergic (drug effects)
  • Receptors, Dopamine (drug effects)
  • Receptors, Serotonin (drug effects)
  • Serotonin (metabolism)
  • Serotonin Agents (pharmacology)
  • Substance Abuse Detection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: